Skip to content

Prime Medicine PRME Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$19.1M-50.7%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$18.61M+6.3%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$14.78M+11.9%
Regenxbio logo
RegenxbioRGNX
$7.87M-0.9%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$11.2M-15.6%
Sana Biotechnology logo
Sana BiotechnologySANA
$14.88M+14.4%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$50.7M+3.3%
Net income-$49.1M+5.3%
EPS (diluted)-$0.28+30.0%

Balance sheet

See full
Cash & equivalents$77.8M-26.6%
Total debt$114.5M-5.5%
Total equity$76.7M-28.3%
Total assets$294.7M-10.2%

Cash flow

See full
Operating cash flow-$42.7M+12.6%
CapEx$214.0K-91.2%
Free cash flow-$42.9M+16.3%

Valuation

See full
Market cap$574.36M+111%
Enterprise value$611.08M+113%
P/S124×+6.3×

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-216.1%+1,519pp
Debt / equity1.5×+0.4×
Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Prime Medicine's operating lease liabilities (current)?
Prime Medicine (PRME) reported operating lease liabilities (current) of $8.55M in Q1 2026.
How has Prime Medicine's operating lease liabilities (current) changed year-over-year?
Prime Medicine's operating lease liabilities (current) increased by 24.6% year-over-year, from $6.86M to $8.55M.
What is the long-term trend for Prime Medicine's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Prime Medicine's operating lease liabilities (current) has grown at a 24.7% compound annual growth rate (CAGR), from $2.7M to $8.14M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.